Skip to main content
Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.090
-0.010 (-0.24%)
At close: Apr 28, 2026, 4:00 PM EDT
4.090
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Aquestive Therapeutics Revenue

In the year 2025, Aquestive Therapeutics had annual revenue of $44.55M, down -22.61%. Aquestive Therapeutics had revenue of $13.02M in the quarter ending December 31, 2025, with 9.67% growth.

Revenue (ttm)
$44.55M
Revenue Growth
-22.61%
P/S Ratio
11.18
Revenue / Employee
$303,027
Employees
147
Market Cap
499.16M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202544.55M-13.02M-22.61%
Dec 31, 202457.56M6.98M13.80%
Dec 31, 202350.58M2.90M6.09%
Dec 31, 202247.68M-3.15M-6.20%
Dec 31, 202150.83M4.98M10.87%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Tilray Brands 858.28M
Emergent BioSolutions 742.90M
Esperion Therapeutics 403.14M
Evolus 297.18M
Ironwood Pharmaceuticals 296.15M
Akebia Therapeutics 236.20M
Canopy Growth 203.04M
Kamada 180.46M
Revenue Rankings

AQST News

More News